About the Authors

Oussama Mouri, Marie Passet, Nathalie Chartrel, Isabelle Joly, Marc Thellier, Dominique Mazier, Pierre Buffet
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service Parasitologie-Mycologie, Paris, France

Gloriat Morizot
Unité d'Immunologie Moléculaire des Parasites, Institut Pasteur de Paris, Paris, France

Gert Van der Auwera
Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

Christophe Ravel
Centre National de Référence des Leishmanioses, Montpellier, France

Marc Thellier, Stéphane Jauréguiberry, Eric Caumes, Dominique Mazier, Carine Marinach-Patrice, Pierre Buffet
Université Pierre et Marie Curie-Paris6, UMR S945 Paris, France

Marc Thellier, Dominique Mazier, Carine Marinach-Patrice, Pierre Buffet
Institut National de la Santé et de la Recherche Médicale U945, Paris, France

Stéphane Jauréguiberry, Eric Caumes
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Maladie Infectieuse, Paris, France

Corresponding Author

pierre.buffet@upmc.fr

Competing Interests

I have read the journal's policy and have the following conflicts: PB provided consultancy for Sanofi-Aventis on the therapy of leishmaniasis and received payment from Sanfoi-Aventis for development of educational presentations. This does not alter our adherence to all PLOS policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: PB DM OM CMP. Performed the experiments: OM CMP. Analyzed the data: PB OM CMP CR. Wrote the paper: PB OM CMP EC CR. Contributed vital samples/information/materials/tools: EC SJ MP IJ MT GM NC GVdA CR.